Text Size

Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01165788
First received: July 16, 2010
Last updated: March 26, 2013
Last verified: March 2013
History of Changes
  Purpose
  1. To explore specific aspects of social adaptation such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT).
  2. To investigate how social adaptation varies with time lapsed since BMT and with the life stage as determined by patient?s age. Understanding both the positive and negative aspects of cancer and cancer therapy leads to opportunities to promote adaptive strategies.

Condition Intervention
Social Adaptation
 Procedure: Semi structured personal interview

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Retrospective
Official Title: Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Specific aspects of social adaptation, such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Social adaptation variation with time lapsed since BMT and with the life stage as determined by patient's age [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 50
Study Start Date: November 2009
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
autologous BMT recipients
Lymphoma patients who received an autologous BMT as adults
 Procedure: Semi structured personal interview
A trained research assistant will conduct in-person, in-depth semi-structured interviews at a location of the participants choosing. Participants will be asked to discuss their experiences with cancer, focusing especially on how their cancer affected their (1) work/education (2) relationships with their family (spouse, children, parents, siblings and other relatives) (3) their other social relationships

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects will be identified from the comprehensive database of the Blood and Marrow Transplant Division of Stanford Hospitals & Clinics. We will target lymphoma patients who received an autologous BMT as adults (18 years or older). We estimate there are ~580 surviving who are between 2 and 22 years post-BMT.

Criteria

Inclusion Criteria:

  1. Lymphoma patients treated with blood and marrow transplantation at Stanford University Medical Center
  2. Age > 18 years at the time of transplant
  3. English speaking
  4. Willingness to sign a written informed consent document
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01165788

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Ginna Laport Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01165788     History of Changes
Other Study ID Numbers: BMT216, SU-07092010-6496
Study First Received: July 16, 2010
Last Updated: March 26, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Blood and Marrow Transplant (BMT)

ClinicalTrials.gov processed this record on May 21, 2013